Primary

Oncology·MeSH: Ovarian Neoplasms
178 drugs in development·97 companies·1 clinical trial
Get the AI investment thesis on Primary

Drug Pipeline by Phase

Approved(51)
DrugCompany
ASCENIVADMA BIOLOGICS, INC. (ADMA)
aveedEndo LP (NDOI)
Aybintio (SB8)Organon & Co. (OGN)
BIVIGAMADMA BIOLOGICS, INC. (ADMA)
celecoxibMiromatrix Medical Inc. (MIRO)
celecoxibACADIA PHARMACEUTICALS INC (ACAD)
celecoxibAptinyx Inc. (APTX)
celecoxibZomedica Corp. (ZOMDF)
celecoxibAlphaTON Capital Corp (ATON)
cinacalcetDR REDDYS LABORATORIES LTD (RDY)
clopidogrel biTeva Pharmaceutical Industries Limited (TEVA)
colesevelamImpax Laboratories, LLC (IPXL)
colestipolANI PHARMACEUTICALS INC (ANIP)
cutaquigKORU Medical Systems Inc. Common Stock (DE) (KRMD)
cuvitruKORU Medical Systems Inc. Common Stock (DE) (KRMD)
diclofenacZomedica Corp. (ZOMDF)
doxorubicinAmneal Pharmaceuticals, Inc. (AMRX)
elahereImmunoGen, Inc. (IMGN)
ermezaMylan II B.V. (MYL)
fenofibrateAmneal Pharmaceuticals, Inc. (AMRX)
fenofibrateANI PHARMACEUTICALS INC (ANIP)
FILSPARI®Travere Therapeutics, Inc. (TVTX)
fycompaCATALYST PHARMACEUTICALS, INC. (CPRX)
FYCOMPA®CATALYST PHARMACEUTICALS, INC. (CPRX)
gammagard liquidKORU Medical Systems Inc. Common Stock (DE) (KRMD)
hizentraKORU Medical Systems Inc. Common Stock (DE) (KRMD)
hydrocortisoneImpax Laboratories, LLC (IPXL)
keveyisStrongbridge Biopharma plc (SBBP)
KeveyisXeris Biopharma Holdings, Inc. (XERS)
lamotrigineTeva Pharmaceutical Industries Limited (TEVA)
levetiracetamMylan II B.V. (MYL)
levetiracetam inNEXUS BIOPHARMA INC (NEXS)
lymphoseek kitCardinal Health Inc. (CAH)
nexletolEsperion Therapeutics, Inc. (ESPR)
nexlizetEsperion Therapeutics, Inc. (ESPR)
ocalivaINTERCEPT PHARMACEUTICALS, INC. (ICPT)
OXLUMOALNYLAM PHARMACEUTICALS, INC. (ALNY)
pitavastatinMylan II B.V. (MYL)
prasugrelMylan II B.V. (MYL)
QbrexzaJourney Medical Corp (DERM)
rivflozaNovo Nordisk A/S (NVO)
teriparatideAmphastar Pharmaceuticals, Inc. (AMPH)
testosteroneAmneal Pharmaceuticals, Inc. (AMRX)
testosterone enanthateNEXUS BIOPHARMA INC (NEXS)
topiramateDR REDDYS LABORATORIES LTD (RDY)
topiramateTeva Pharmaceutical Industries Limited (TEVA)
triamcinolone acetonideTeva Pharmaceutical Industries Limited (TEVA)
Trokendi XRSUPERNUS PHARMACEUTICALS, INC. (SUPN)
vonjoCTI BIOPHARMA CORP (CTIC)
xembifyKORU Medical Systems Inc. Common Stock (DE) (KRMD)
zejulaTESARO, Inc. (TSRO)
Phase 3(56)
DrugCompany
2mg cs0159West Pharmaceutical Services Inc. (WST)
alxn1920ALEXION PHARMACEUTICALS, INC. (ALXN)
Antineoplastons (A10 & AS2-1)BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons A10 and AS2-1BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
aramcholGalmed Pharmaceuticals Ltd. (GLMD)
baxdrostatASTRAZENECA PLC (AZN)
BelimumabCrinetics Pharmaceuticals, Inc. (CRNX)
bezafibrateINTERCEPT PHARMACEUTICALS, INC. (ICPT)
bivv009Bioverativ Inc. (BIVV)
dcr-phxcDicerna Pharmaceuticals Inc (DRNA)
DMT410Dermata Therapeutics Inc. (DRMA)
eltrombopagNovartis AG (NVS)
EltrombopagNovartis AG (NVS)
epcoritamabGH Research PLC (GHRS)
fdcINTERCEPT PHARMACEUTICALS, INC. (ICPT)
FelzartamabBIOGEN INC. (BIIB)
FOLFOXKYNTRA BIO INC. (KYNB)
FOLFOX+QL1706+CetuximabKYNTRA BIO INC. (KYNB)
hbm9161 dose aQ BioMed Inc. (QBIO)
hbm9161 dose bQ BioMed Inc. (QBIO)
hmpl-523HUTCHMED (China) Ltd (HMDCF)
ianalumabMerus N.V. (MRUS)
IbrutinibMerck & Co., Inc. (MRK)
immune globulinTAKEDA PHARMACEUTICAL CO LTD (TKPHF)
IMVT-1401Immunovant, Inc. (IMVT)
kte-c19Kite Pharma, Inc. (KITE)
lnp023Novartis AG (NVS)
lnp023Novartis AG (NVS)
LumasiranALNYLAM PHARMACEUTICALS, INC. (ALNY)
MultikineCEL SCI CORP (CVM)
nofazinlimabEQRx, Inc. (EQRX)
ocaINTERCEPT PHARMACEUTICALS, INC. (ICPT)
oca + bezafibrateINTERCEPT PHARMACEUTICALS, INC. (ICPT)
orelabrutinibZenas BioPharma, Inc. (ZBIO)
PD -1/PD-L1 monoclonal antibodyENANTA PHARMACEUTICALS INC (ENTA)
pelabresibNovartis AG (NVS)
pelabresibNovartis AG (NVS)
Recombinant Interferon Alfa-2bENANTA PHARMACEUTICALS INC (ENTA)
seladelparGILEAD SCIENCES, INC. (GILD)
SurovatamigASTRAZENECA PLC (AZN)
tacrolimusBIOGEN INC. (BIIB)
tak-079Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-771Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-771TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-881TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-881Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
telitaciceptVor Biopharma Inc. (VOR)
temozolomideWest Pharmaceutical Services Inc. (WST)
tirabrutinibEton Pharmaceuticals, Inc. (ETON)
tirabrutinibWest Pharmaceutical Services Inc. (WST)
tirabrutinibDeciphera Pharmaceuticals, Inc. (DCPH)
volixibatMirum Pharmaceuticals, Inc. (MIRM)
xen1101Xenon Pharmaceuticals Inc. (XENE)
XeominRevance Therapeutics, Inc. (RVNC)
Phase 2(25)
DrugCompany
2mg cs0159X4 Pharmaceuticals, Inc (XFOR)
ADX-2191Aldeyra Therapeutics, Inc. (ALDX)
ALXN1920ARS Pharmaceuticals, Inc. (SPRY)
anti-human ccl24 monoclonal antibodyChemomab Therapeutics Ltd. (CMMB)
Bexotegrast (PLN-74809)PLIANT THERAPEUTICS, INC. (PLRX)
Brentuximab VedotinFilana Therapeutics Inc. (FLNA)
cin-107CinCor Pharma, Inc. (CINC)
cin-107 2 mg dosingASTRAZENECA PLC (AZN)
cin-107 4 mg dosingASTRAZENECA PLC (AZN)
cin-107 8 mg dosingASTRAZENECA PLC (AZN)
CNP-104IRONWOOD PHARMACEUTICALS INC (IRWD)
DaratumumabFATE THERAPEUTICS INC (FATE)
Daratumumab SCFATE THERAPEUTICS INC (FATE)
EncorafenibADMA BIOLOGICS, INC. (ADMA)
EncorafenibRelay Therapeutics, Inc. (RLAY)
IMVT-1402Immunovant, Inc. (IMVT)
nedosiranDicerna Pharmaceuticals Inc (DRNA)
ngm282NGM BIOPHARMACEUTICALS INC (NGM)
OrelabrutinibENANTA PHARMACEUTICALS INC (ENTA)
PLN-74809PLIANT THERAPEUTICS, INC. (PLRX)
sbi-100 ophthalmic emulsionSkye Bioscience, Inc. (SKYE)
SetanaxibCalliditas Therapeutics AB (CALT)
thrombopoietin receptor agonistNovartis AG (NVS)
thrombopoietin receptor agonistNOVARTIS AG (NVSEF)
thrombopoietin receptor agonistMerus N.V. (MRUS)
Phase 1(16)

Compare drugs

Frequently asked questions

How many drugs are in development for Primary?

BioSniper tracks 178 drugs in development for Primary across 97 companies.

How many clinical trials target Primary?

There are 1 clinical trial targeting Primary tracked by BioSniper.

Analyze ADMA BIOLOGICS, INC.'s Primary pipeline with AI

Full trial data, competitive analysis, and AI-powered pipeline tracking.

  • 200 free AI credits / month to run live multi-agent analysis
  • Watchlist, catalyst alerts & the biotech event calendar
  • Full pipeline, financials & FDA data on every company
Start AI Analysis